Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1. 2014

Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
The Hormel Institute University of Minnesota, 801 16 Ave NE, Austin, MN 55912. zgdong@hi.umn.edu.

The c-Jun N-terminal kinases (JNK) play an important role in many physiologic processes induced by numerous stress signals. Each JNK protein appears to have a distinct function in cancer, diabetes, or Parkinson's disease. Herein, we found that licochalcone A, a major phenolic constituent isolated from licorice root, suppressed JNK1 activity but had little effect on JNK2 in vitro activity. Although licochalcone A binds with JIP1 competitively with either JNK1 or JNK2, a computer simulation model showed that after licochalcone A binding, the ATP-binding cleft of JNK1 was distorted more substantially than that of JNK2. This could reduce the affinity of JNK1 more than JNK2 for ATP binding. Furthermore, licochalcone A inhibited JNK1-mediated, but not JNK2-mediated, c-Jun phosphorylation in both ex vivo and in vitro systems. We also observed that in colon and pancreatic cancer cell lines, JNK1 is highly expressed compared with normal cell lines. In cancer cell lines, treatment with licochalcone A or knocking down JNK1 expression suppressed colon and pancreatic cancer cell proliferation and colony formation. The inhibition resulted in G1 phase arrest and apoptosis. Moreover, an in vivo xenograft mouse study showed that licochalcone A treatment effectively suppressed the growth of HCT116 xenografts, without affecting the body weight of mice. These results show that licochalcone A is a selective JNK1 inhibitor. Therefore, we suggest that because of the critical role of JNK1 in colon cancer and pancreatic carcinogenesis, licochalcone A might have preventive or therapeutic potential against these devastating diseases.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme

Related Publications

Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
July 2009, FEBS letters,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
August 2023, European journal of medicinal chemistry,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
July 1996, Cancer research,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
January 2020, Computational and structural biotechnology journal,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
December 2021, Journal of medicinal chemistry,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
January 2022, Cancer gene therapy,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
February 2001, The EMBO journal,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
December 2015, Journal of medical virology,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
March 2008, Biochemistry,
Ke Yao, and Hanyong Chen, and Mee-Hyun Lee, and Haitao Li, and Weiya Ma, and Cong Peng, and Nu Ry Song, and Ki Won Lee, and Ann M Bode, and Ziming Dong, and Zigang Dong
November 1997, Biochemistry,
Copied contents to your clipboard!